The COVID-19 Scientific Interest Group was created in March 2020 in response to the COVID-19 pandemic. This interest group aims to promote collaboration and facilitate the exchange of information and resources among NIH intramural scientists and their HHS colleagues concerning research on COVID-19 and SARS-CoV-2.
COVID-19 SIG created an email listserv in March 2020 in response to the COVID-19 outbreak intended for NIH scientists to exchange information concerning research on COVID-19 and SARS-CoV-2.
Main Areas of Focus
The virology of SARS-CoV-2 including viral genome, viral protein structure/function relationships, and viral pathogenesis
The resulting disease of SARS-CoV-2 infection called COVID-19. Areas of interest include animal models of COVID-19, clinical manifestations in patients, disease biomarkers, long-term effects of COVID-19, and therapeutics including biologics, small molecules, and vaccines.
The COVID-19 SIG lecture series facilitates communication of the ongoing scientific research to understand SARS-CoV-2 and treat COVID-19. Invited speakers share the latest research on a broad range of topics, including clinical findings, therapeutics, basic biology, epidemiology, and public health research. This lecture series runs from October through June.
Research in NIH Labs
The COVID-19 Scientific Interest Group, in collaboration with the Trans-NIH Preclinical Working Group, created an NIH Intramural Research Program (IRP) inventory and dashboard of COVID-19 projects. Currently, this dashboard can be accessed only by NIH leadership and the researchers who contributed information to it.
COVID SIG also offers lists open to the public.